Ypsomed Holding AG (YPSN.SW)
- Previous Close
339.00 - Open
342.00 - Bid 335.00 x --
- Ask 342.00 x --
- Day's Range
334.50 - 344.00 - 52 Week Range
207.50 - 389.50 - Volume
20,107 - Avg. Volume
15,476 - Market Cap (intraday)
4.606B - Beta (5Y Monthly) 0.98
- PE Ratio (TTM)
63.32 - EPS (TTM)
5.33 - Earnings Date May 22, 2024
- Forward Dividend & Yield 1.30 (0.39%)
- Ex-Dividend Date Jul 3, 2023
- 1y Target Est
177.50
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. The company operates through two segments, Ypsomed Delivery Systems and Ypsomed Diabetes Care. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services. It markets its products through pharmaceutical partners, as well as through its own distribution network and independent distributors. It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.
www.ypsomed.comRecent News: YPSN.SW
Performance Overview: YPSN.SW
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: YPSN.SW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: YPSN.SW
Valuation Measures
Market Cap
4.61B
Enterprise Value
4.74B
Trailing P/E
63.32
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
9.05
Price/Book (mrq)
8.03
Enterprise Value/Revenue
9.32
Enterprise Value/EBITDA
29.86
Financial Highlights
Profitability and Income Statement
Profit Margin
14.24%
Return on Assets (ttm)
4.61%
Return on Equity (ttm)
13.38%
Revenue (ttm)
508.61M
Net Income Avi to Common (ttm)
72.42M
Diluted EPS (ttm)
5.33
Balance Sheet and Cash Flow
Total Cash (mrq)
36.38M
Total Debt/Equity (mrq)
35.38%
Levered Free Cash Flow (ttm)
-75.83M
Research Analysis: YPSN.SW
Analyst Price Targets
Fair Value
No Fair Value available for this ticker
Company Insights: YPSN.SW
YPSN.SW does not have Company Insights